{"organizations": [], "uuid": "19a5db8fa88ec40bef17cbb8acdf347bb3558d8a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-clovis-oncology-announces-pricing/brief-clovis-oncology-announces-pricing-of-public-offerings-of-convertible-senior-notes-and-common-stock-idUSASC09W1V", "country": "US", "domain_rank": 408, "title": "BRIEF-Clovis Oncology Announces Pricing Of Public Offerings Of Convertible Senior Notes And Common Stock", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-17T03:58:00.000+03:00", "replies_count": 0, "uuid": "19a5db8fa88ec40bef17cbb8acdf347bb3558d8a"}, "author": "", "url": "https://www.reuters.com/article/brief-clovis-oncology-announces-pricing/brief-clovis-oncology-announces-pricing-of-public-offerings-of-convertible-senior-notes-and-common-stock-idUSASC09W1V", "ord_in_thread": 0, "title": "BRIEF-Clovis Oncology Announces Pricing Of Public Offerings Of Convertible Senior Notes And Common Stock", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "none"}, {"name": "clovis oncology inc", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 16 (Reuters) - Clovis Oncology Inc:\n* CLOVIS ONCOLOGY ANNOUNCES PRICING OF PUBLIC OFFERINGS OF CONVERTIBLE SENIOR NOTES AND COMMON STOCK\n* CLOVIS ONCOLOGY INC- PRICING OF AN UNDERWRITTEN PUBLIC OFFERING OF $300 MILLION AGGREGATE PRINCIPAL AMOUNT OF ITS 1.25% CONVERTIBLE SENIOR NOTES DUE 2025\n* CLOVIS ONCOLOGY- ANNOUNCED PRICING OF 1.8 MILLION SHARES OF ITS COMMON STOCK IN AN UNDERWRITTEN PUBLIC OFFERING AT A PRICE TO PUBLIC OF $54.41 PER SHARE\n* CLOVIS ONCOLOGY INC - PRICED $300 MILLION AGGREGATE PRINCIPAL AMOUNT OF CONVERTIBLE SENIOR NOTES AT PRICE TO PUBLIC OF 100% OF PRINCIPAL AMOUNT OF NOTES Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-04-17T03:58:00.000+03:00", "crawled": "2018-04-17T04:18:25.020+03:00", "highlightTitle": ""}